CSL Behring Delivers on its Promise to Advance Bleeding Disord...
MELBOURNE, Australia, July 2, 2019 /PRNewswire-AsiaNet/ -- -- Novel real world evidence for AFSTYLA(R) and IDELVION(R) to be highlighted Global biotherapeutics leader CSL Behring ( https://c212.net/c/link/?t=0&l=en&o=2514141-1&h=2330612868&u=http%3A%2F%2Fwww.cslbehring.com%2F&a=CSL+Behring ) announced...
Authors: LATEST ASIANET NEWS RELEASES